"I was leading a blind patient down the hall and told him to watch his step. He just laughed and said, 'Well, that’s not ...

In recent years, while the market size for entertainment content has expanded, many companies are facing a hiring wall: they ...

Meta open-sources Rebalancer, the Apache 2.0 C++ solver behind 40 million daily assignment problems across its global infrastructure.

Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home. Credit...Video by Harsha Vadlamani Supported by By Alex Travelli ...

Illinois residents who purchased a generic drug between May 2009 and December 2019 could be eligible for payouts as part of a series of allegations that drug companies conspired to manipulate prices.

In Morgan Stanley’s fireside chat on September 14, ANI Pharmaceuticals’ (ANIP) CEO Nikhil Lalwani described their business as twofold: the generic business and the rare-disease one. The problem, as we ...

If you take a patented, brand-name medication — a cancer biologic, an autoimmune drug, a specialty injection — the supply chain behind that drug is about to be permanently restructured, starting at 12 ...

Par Health has launched the first generic formulation of Janumet XR in 3 extended-release dosage strengths, offering a lower-cost alternative for glycemic control. Par Health announced the ...

U.S. President Donald Trump's plan to impose tariffs on generic drugs will lead to patients in the U.S. paying higher prices, warned the CEO of Indian pharmaceutical company Dr Reddy's. Manufacturing ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...

Shares in several European and Asian makers of generic medicines fell after President Trump said the U.S. would place tariffs on such drugs starting in August 2028. In European afternoon trading ...